Immunosuppressants reduce venous thrombosis relapse in Behçet's disease

Arthritis and Rheumatism
A C DesboisDavid Saadoun

Abstract

To investigate and describe the long-term outcome of venous thrombosis in patients with Behçet's disease (BD). In a retrospective cohort of 807 BD patients, a reported 296 patients (36.7%) (73.3% male, median age 30 years [interquartile range 24-36 years]) met the international classification criteria for BD and had venous thrombosis. We assessed factors associated with thrombosis relapse and mortality. There were a total of 586 venous thrombosis events, including 560 cases of deep thrombosis and 26 cases of superficial thrombosis. Deep venous thrombosis events included 323 cases of limb thrombosis (55.1%), 77 cases of cerebral venous thrombosis (13.1%), 57 cases of pulmonary embolism (9.7%), 63 cases of vena cava lesions (10.7%), 14 cases of Budd-Chiari syndrome (2.4%), and 13 cases of cervical vein thrombosis (2.2%). One hundred of 296 patients (33.8%) experienced at least 1 venous thrombosis relapse. The mortality rate was 6.4% (19 of 296 patients) after a median followup of 4.75 years (interquartile range 2-7 years). In univariate analysis, death was associated with cardiac involvement (P = 0.026) and Budd-Chiari syndrome (P = 0.004). In multivariate analysis, the use of immunosuppressive agents was found to prevent relapse...Continue Reading

References

Jun 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E BismuthJ P Benhamou
Nov 1, 1994·World Journal of Surgery·M A KuzuA Tüzüner
Oct 21, 1999·The New England Journal of Medicine·T SakaneG Inaba
Jan 10, 2001·Current Opinion in Rheumatology·H YaziciV Hamuryudan
Jan 29, 2002·The American Journal of Medicine·Gerard EspinosaJoan-Carles Reverter
Oct 18, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Aline TohméElie Ghayad
Oct 14, 2004·Annals of the Rheumatic Diseases·M LeibaM Ehrenfeld
Feb 10, 2006·Scandinavian Journal of Rheumatology·N DüzgünU Olmez
Aug 17, 2006·International Journal of Dermatology·Rifkiye Sarica-KucukogluGulsevim Azizlerli
Feb 5, 2008·Annals of the Rheumatic Diseases·G HatemiUNKNOWN EULAR Expert Committee
Apr 28, 2010·Rheumatology·Puja MehtaDorian O Haskard
May 25, 2010·Arthritis and Rheumatism·D SaadounP Cacoub
Dec 3, 2010·Current Opinion in Rheumatology·Kenneth T CalamiaMelike Melikoglu

❮ Previous
Next ❯

Citations

Mar 20, 2013·Best Practice & Research. Clinical Rheumatology·Angelo L Gaffo
Nov 13, 2012·Current Opinion in Rheumatology·Jason Springer, Alexandra Villa-Forte
Jul 23, 2013·Current Opinion in Rheumatology·Seza Ozen, Fehime K Eroglu
Nov 17, 2012·Drugs·Sam R DalviYusuf Yazici
Jan 18, 2014·La Revue de médecine interne·A-C DesboisD Saadoun
Jan 21, 2014·La Revue de médecine interne·C ComarmondD Saadoun
Jul 9, 2013·Immunotherapy·Cloé ComarmondDavid Saadoun
Jul 1, 2014·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Christophe SeinturierPatrick Henri Carpentier
Jul 6, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Monika MocholEmilia Kerty
Dec 3, 2014·Journal des maladies vasculaires·H NaouliA Bouarhroum
Nov 18, 2014·Rheumatic Diseases Clinics of North America·Ora Singer
Feb 19, 2016·Pediatric Rheumatology Online Journal·Isabelle Koné-Paut
Feb 13, 2016·Auto- Immunity Highlights·Mohamad J ZeidanPatrice Cacoub
May 3, 2015·The American Journal of Case Reports·Yılmaz BaşAyşegül Taylan Özkan
May 13, 2015·Heart and Vessels·Iman H BassyouniHossam M Mansour
Sep 13, 2014·Orphanet Journal of Rare Diseases·Anne Claire DesboisAurélie Plessier
Feb 19, 2015·Current Rheumatology Reports·Lauren E Wong, Anne R Bass
Mar 13, 2014·Current Opinion in Rheumatology·Yesim OzgulerHasan Yazici
Apr 12, 2018·The New England Journal of Medicine·Harrison W FarberJames R Stone
Apr 18, 2018·International Journal of Rheumatic Diseases·Fatma Alibaz-Oner, Haner Direskeneli
Dec 19, 2014·The Cochrane Database of Systematic Reviews·Francesca NavaIrene Tramacere
Aug 17, 2018·Ophthalmic Surgery, Lasers & Imaging Retina·Inés HernanzEster Carreño
Apr 8, 2018·Annals of the Rheumatic Diseases·Gulen HatemiHasan Yazici
Feb 4, 2014·The Journal of Rheumatology·Gulen HatemiHasan Yazici
Oct 17, 2013·Clinical and Experimental Immunology·G A RamirezA A Manfredi
Oct 4, 2019·Angiology·Pablo Ruiz SadaUNKNOWN RIETE Investigators
Sep 11, 2019·Rheumatology·Yesim OzgulerMelike Melikoglu
Apr 30, 2020·Rheumatology·Omer Karadag, Ertugrul Cagri Bolek
Sep 23, 2014·BMJ Case Reports·Muhammet BiliciBunyamin Kisacik
Jun 20, 2013·Arthritis and Rheumatism·Nicolas NoelDavid Saadoun
Dec 30, 2014·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Khaled AlderaanUsama H M Ismail
Nov 3, 2017·Rheumatology International·Rainer HintenbergerHerwig Pieringer
Oct 28, 2017·Current Opinion in Rheumatology·Mira MerashliImad Uthman
Apr 24, 2018·Annals of Vascular Diseases·Hiroyuki Ishibashi
May 31, 2019·Annals of the Rheumatic Diseases·Alexandre Le JoncourYacine Boulaftali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.